Don't need to call anyone. Know the business.
I don't need to call Schmitt or Perlowin, as nearly all of my calls about HEMP's business have been correct so far. I understand their business accumen, or lack thereof.
We know that Biotech Mills went bankrupt selling the same product that HEMP says it intends to make, and we know that the profit margins couldn't support their business.
We also know that Perlowin hasn't been successful in achieving any of the goals he's set in the last couple of years.
1Q/15 will show a large loss, as will 2Q/15. 3Q/15 might show some revenue if they get the decorticator running, but again, we'll see a loss.
Meanwhile, the share count will continue to rise.
News 
Market Data 
Discover 
